Chitosan (or alginate)-coated iron oxide nanoparticles: A comparative study

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 468, Issue , 2015, Pages 151-158

  Castelló, Júlia ^a   Gallardo, Montserrat ^a,b   Busquets, Maria Antònia ^a,b   Estelrich, Joan ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alginate coated iron oxide; Chitosan coated iron oxide; Ferrofluid; Magnetic nanoparticles; Nanostructured materials; Thermal analysis

Indexed keywords

ALGINATE; CHITOSAN; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; IRON OXIDES; MAGNETIC FLUIDS; MEDICAL APPLICATIONS; METAL NANOPARTICLES; NANOSTRUCTURED MATERIALS; PHASE SEPARATION; PLASTIC COATINGS; PRECIPITATION (CHEMICAL); SATURATION MAGNETIZATION; SUPERPARAMAGNETISM; SUSPENSIONS (FLUIDS); SYNTHESIS (CHEMICAL); THERMOANALYSIS; THERMOGRAVIMETRIC ANALYSIS;

AQUEOUS SUSPENSIONS; BIOMEDICAL APPLICATIONS; COATED NANOPARTICLES; COPRECIPITATION METHOD; IRON OXIDE NANOPARTICLE; OPTIMAL CONCENTRATION; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC PROPERTY;

MAGNETIC NANOPARTICLES;

ALGINIC ACID; CHITOSAN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ADSORPTION; ARTICLE; COMPARATIVE STUDY; HYDRODYNAMICS; PARTICLE SIZE; PHASE SEPARATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84920913812     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2014.12.031     Document Type: Article

References (46)

1. Warner S. Diagnostics plus therapy=theranostics. Scientist 2004, 18:38-39.
2. Wang L.S., Chuang M.C., Ho J.A. Nanotheranostics - a review of recent publications. Int. J. Nanomed. 2012, 7:4679-4695.
3. Murray C.B., Kagan C.R., Bawendi M.G. Synthesis and characterization of monodisperse nanocrystals and close-packed nanocrystal assemblies. Annu. Rev. Mater. Sci. 2000, 30:545-610.
4. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliv. Rev. 2008, 60:1241-1251.
5. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 2009, 38:372-390.
6. Xie J., Huang J., Li X., Sun S., Chen X. Iron oxide nanoparticle platform for biomedical applications. Curr. Med. Chem. 2009, 16:1278-1294.
7. Lacroix L.M., Ho D., Sun S.H. Magnetic nanoparticles as both imaging probes and therapeutic agents. Curr. Top. Med. Chem. 2010, 10:1184-1197.
8. Jarrett B.R., Frendo M., Vogan J. Size-controlled synthesis of dextran sulfate coated iron oxide nanoparticles for magnetic resonance imaging. Nanotechnology 2007, 18:35603-35610.
9. 4 nanoparticles. J. Magn. Magn. Mater. 2006, 304:e415-e417.
10. Paul K.G., Frigo T.B., Groman J.Y., Groman E.V. Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. Bioconjug. Chem. 2004, 15:394-401.
11. Pardoe H., Chua-Anusorn W., St.Pierre T.G., Dobson J. Structural and magnetic properties of nanoscale iron oxide particles synthesized in the presence of dextran or polyvinyl alcohol. J. Magn. Magn. Mater. 2001, 225:41-46.
12. Mandel K., Hutter F., Gellermann C., Sextl C. Synthesis and stabilisation of superparamagnetic iron oxide nanoparticle dispersions. Colloids Surf. A 2011, 390:173-178.
13. Yue-Jian C., Juan T., Fei X., Jia-Bi Z., Ning G., Hi-Hua Z., Ye D., Liang G. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Dev. Ind. Pharm. 2010, 36:1235-1244.
14. Schweiger C., Pietzonka C., Heverhagen J., Kissel T. Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential medical application: synthesis, stability, cytotoxicity and MR imaging. Int. J. Pharm. 2011, 408:130-137.
15. Brullot W., Reddy N.K., Wouters J., Valev V.K., Goderis B., Vermant J., Verbiest T. Versatile ferrofluids based on polyethylene glycol coated iron oxide nanoparticles. J. Magn. Magn. Mater. 2012, 324:1919-1925.
16. García-Jimeno S., Estelrich J. Ferrofluid based on polyethylene glycol-coated iron oxide nanoparticles: characterization and properties. Colloids Surf. A 2013, 420:74-81.
17. Lu C., Liu P. Effect of chitosan multilayers encapsulation on controlled release performance of drug-loaded superparamagnetic alginate nanoparticles. J. Mater. Sci.: Mater. Med. 2012, 23:393-398.
18. Li L., Chen D., Zhang Y., Deng Z., Reng X., Meng X., Tang F., Ren J., Zhang L. Magnetic and fluorescent multifunctional chitosan nanoparticles as a smart drug delivery system. Nanotechnology 2007, 18:405102.
19. Shen J.M., Xu L., Lu Y., Cao H.M., Xu Z.G., Chen T., Zhang H.X. Chitosan-based luminescent/magnetic hybrid nanogels for insulin delivery, cell imaging, and antidiabetic research of dietary supplements. Int. J. Pharm. 2012, 427:400-409.
20. Shokrollahi H. Structure, synthetic methods, magnetic properties and biomedical applications of ferrofluids. Mater. Sci. Eng. C 2013, 33:2476-2487.
21. Arami H., Stephen Z., Veiseh O., Zhang M. Chitosan-coated iron oxide nanoparticles for molecular imaging and drug delivery. Chitosan for Biomaterials I, Advances in Polymer Science 2011, vol. 234:163-184. Springer, Berlin, Heidelberg.
22. George M., Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review. J. Control. Release 2006, 114:1-14.
23. Agrawal P., Strijkers G.J., Nikolay K. Chitosan-based systems for molecular imaging. Adv. Drug Deliv. Rev. 2010, 62:42-58.
24. Tonnesen H.H., Karlsen J. Alginate in drug delivery systems. Drug Dev. Ind. Pharm. 2002, 28:621-630.
25. Lee K.Y., Mooney D.J. Alginate: properties and biomedical applications. Prog. Polym. Sci. 2012, 37:106-126.
26. Jayakumar R., Menon D., Manzoor K., Nair S.V., Tamura H. Biomedical applications of chitin and chitosan based nanomaterials - a short review. Carbohydr. Polym. 2010, 82:227-232.
27. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans. Magn. 1981, 17:1247-1248.
28. Golas P.L., Louie S., Lowry G.V., Matyjaszewski K., Tilton R.D. Comparative study of polymeric stabilizers for magnetite nanoparticles using ATRP. Langmuir 2010, 26:16890-16990.
29. Roe J.M. The determination of sugar in blood and spinal fluid with anthrone reagent. J. Biol. Chem. 1955, 212:335-343.
30. 4 magnetic nanoparticles for removal of Cu(II) ions. J. Colloid Interface Sci. 2005, 283:446-451.
31. Kiwada H., Sato J., Yamada S., Kato Y. Feasibility of magnetic liposomes as a targeting device for drugs. Chem. Pharm. Bull. 1986, 34:4253-4258.
32. Hunter R.J. Zeta Potential in Colloid Science. Principles and Applications 1988, Academic Press, London.
33. Gnanaprakash G., Mahadevan S., Jayakumar T., Kalyanasundaram P., Philip J., Raj B. Effect of initial pH and temperature iron salt solutions on formation of magnetite nanoparticles. Mater. Chem. Phys. 2007, 103:168-175.
34. Cullity B.D. Elements of X-ray Diffraction 2001, Prentice Hall, Upper Saddle River, NJ.
35. Roohi F., Lohrke J., Ide A., Schütz G., Dassler K. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles. Int. J. Nanomed. 2012, 7:4447-4458.
36. Santana S.D.F., Dhadge V.L., Roque C.A. Dextran-coated magnetic supports modified with a biomimetic ligand for IgG purification. ACS Appl. Mater. Interfaces 2012, 4:5907-5914.
37. Shi S.-F., Jia J.-F., Guo X.-K., Zhao Y.-P., Chen D.-S., Guo Y.-Y., Cheng T., Zhang X.-L. Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells. Int. J. Nanomed. 2012, 7:5593-5602.
38. Bautista M.C., Bomati-Miguel O., Zhao X., Morales M.P., González-Carreño T., Pérez de Alejo R., Ruiz-Cabello J., Veintemillas-Verdaguer S. Comparative study of ferrofluids based on dextran-coated iron oxide and metal nanoparticles for contrast agents in magnetic resonance imaging. Nanotechnology 2004, 15:S154-S159.
39. 4-chitosan composite nanoparticles in an AC magnetic field for localized hyperthermia. J. Alloys Compd. 2009, 477:739-743.
40. Qin C., Li C., Hu Y., Shen J., Ye M. Facile synthesis of magnetic iron oxide nanoparticles using 1-methyl-2-pyrrolidone as a functional solvent. Colloids Surf. A 2009, 336:130-134.
41. 4) nanoparticles and their prevention of the reduction of cytochrome C. ACS Appl. Mater. Interfaces 2012, 4:142-149.
42. van der Steeg H.G.M., Cohen Stuart M.A., de Keizer A., Bijsterbosch B.H. Polyelectrolyte adsorption: a subtle balance of forces. Langmuir 1992, 8:2538-2546.
43. Tombácz E., Bica D., Hadjú A., Illés E., Majzik A., Vékás L. Surfactant double layer stabilized magnetic nanofluids for biomedical application. J. Phys. Condens. Matter. 2008, 20:204103. 6pp.
44. Wiogo H.T.R., Lim M., Balmus V., Yun J., Amal R. Stabilization of magnetic iron oxide nanoparticles in biological media by fetal calf serum (FBS). Langmuir 2011, 27:843-850.
45. Chen Z.P., Xu R.Z., Zhang Y., Gu Y.N. Effects of proteins from culture medium on surface property of silanes-functionalized magnetic nanoparticles. Nanoscale Res. Lett. 2009, 4:204-209.
46. Mu Q., Li Z., Li X., Mishra S.R., Zhang B., Si Z., Yang L., Jiang W., Yan B.J. Characterization of protein clusters of diverse magnetic nanoparticles and their dynamic interactions with cells. Phys. Chem. C 2009, 113:5390-5395.